Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −4.1% | −10.7% | −2.4% | +1.8% | +25.2% | +28.8% | +65.7% | +30.7% | +333.7% | +1,569.6% |
| Peer average | −3.5% | −16.5% | −29.0% | −36.4% | −17.6% | −14.8% | +58.2% | +22.2% | +252.1% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$138 of every $1,000 in RXL is Proshares
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | —Net Other Assets (Liabilities) | — | 22.54% | $2,253.69 | 24.4M | $24.4M |
| 2 | IQMMProshares Genius MNY MKT ETF | Financial Services | 13.84% | $1,384.12 | 150K | $15.0M |
| 3 | LLYELI Lilly | Healthcare | 10.74% | $1,073.87 | 8,424 | $11.6M |
| 4 | JNJJohnson & Johnson | Healthcare | 6.38% | $637.87 | 25K | $6.9M |
| 5 | ABBVAbbvie | Healthcare | 4.91% | $490.57 | 19K | $5.3M |
| 6 | MRKMerck | Healthcare | 3.30% | $329.94 | 26K | $3.6M |
| 7 | UNHUnitedhealth Group | Healthcare | 3.05% | $304.85 | 9,450 | $3.3M |
| 8 | TMOThermo Fisher Scientific | Healthcare | 2.49% | $248.63 | 3,893 | $2.7M |
| 9 | AMGNAmgen | Healthcare | 2.33% | $232.93 | 5,692 | $2.5M |
| 10 | GILDGilead Sciences | Healthcare | 2.03% | $203.38 | 13K | $2.2M |
| 11 | ABTAbbott Laboratories | Healthcare | 1.75% | $175.48 | 18K | $1.9M |
| 12 | PFEPfizer | Healthcare | 1.55% | $155.23 | 60K | $1.7M |
| 13 | ISRGIntuitive Surgical | Healthcare | 1.44% | $144.33 | 3,719 | $1.6M |
| 14 | DHRDanaher | Healthcare | 1.39% | $138.81 | 6,587 | $1.5M |
| 15 | VRTXVertex Pharmaceuticals | Healthcare | 1.32% | $132.00 | 2,669 | $1.4M |
of the $113B in 406 An index ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | IQMM | Proshares Genius MNY MKT ETF | 13.84% |
| 2 | LLY | ELI Lilly & | 10.74% |
| 3 | JNJ | Johnson & Johnson | 6.38% |
| 4 | ABBV | Abbvie | 4.91% |
| 5 | MRK | Merck & | 3.30% |
| 6 | UNH | Unitedhealth Group | 3.05% |
| 7 | TMO | Thermo Fisher Scientific | 2.49% |
| 8 | AMGN | Amgen | 2.33% |
| 9 | GILD | Gilead Sciences | 2.03% |
| 10 | ABT | Abbott Laboratories | 1.75% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 29, 2026 | $0.13 |
| Jun 24, 2026 | Jun 30, 2026 | $0.18 |
| Mar 25, 2026 | Mar 31, 2026 | $0.14 |
| Dec 24, 2025 | Dec 31, 2025 | $0.18 |
| Sep 24, 2025 | Sep 30, 2025 | $0.20 |
| Jun 25, 2025 | Jul 1, 2025 | $0.22 |
| Mar 26, 2025 | Apr 1, 2025 | $0.13 |
| Dec 23, 2024 | Dec 31, 2024 | $0.15 |
| Sep 25, 2024 | Oct 2, 2024 | $0.13 |
| Jun 26, 2024 | Jul 3, 2024 | $0.17 |
| Mar 20, 2024 | Mar 27, 2024 | $0.0861 |
| Dec 20, 2023 | Dec 28, 2023 | $0.0841 |